Roche win boosts case for adding chemo to cancer immunotherapy – Reuters
European Biotechnology |
Roche win boosts case for adding chemo to cancer immunotherapy
Reuters LONDON, Nov 20 (Reuters) – Cancer doctors struggling to work out the best way to use modern immunotherapy drugs now have further evidence of the benefits of adding them to chemotherapy, despite earlier scepticism. News that Roche's immune … Roche chemo-immunotherapy combo mets NSCLC Phase III endpoint Roche reshuffles lung cancer immunotherapy market with positive clinical trial results Roche announces trial successes in cancer, haemophilia |
